129 related articles for article (PubMed ID: 3059053)
1. The mechanism of action of steroid antagonists: insights from crystallographic studies.
Duax WL; Griffin JF; Weeks CM; Wawrzak Z
J Steroid Biochem; 1988 Oct; 31(4B):481-92. PubMed ID: 3059053
[TBL] [Abstract][Full Text] [Related]
2. Structural features which distinguish estrogen agonists and antagonists.
Duax WL; Griffin JF
J Steroid Biochem; 1987; 27(1-3):271-80. PubMed ID: 2826888
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of antisteroid hormones at the receptor level.
Baulieu EE
Kidney Int Suppl; 1988 Oct; 26():S2-7. PubMed ID: 3059030
[No Abstract] [Full Text] [Related]
4. The significance of the 20-carbonyl group of progesterone in steroid receptor binding: a molecular dynamics and structure-based ligand design study.
Hillisch A; von Langen J; Menzenbach B; Droescher P; Kaufmann G; Schneider B; Elger W
Steroids; 2003 Nov; 68(10-13):869-78. PubMed ID: 14667979
[TBL] [Abstract][Full Text] [Related]
5. Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells.
Labrie F; Poulin R; Simard J; Zhao HF; Labrie C; Dauvois S; Dumont M; Hatton AC; Poirier D; Mérand Y
Ann N Y Acad Sci; 1990; 595():130-48. PubMed ID: 2142871
[TBL] [Abstract][Full Text] [Related]
6. A structure-activity relationship study of spirolactones. Contribution of the cyclopropane ring to antimineralocorticoid activity.
Chinn LJ; Salamon KW; Desai BN
J Med Chem; 1981 Sep; 24(9):1103-7. PubMed ID: 6270335
[TBL] [Abstract][Full Text] [Related]
7. A-ring conformational stability and progesterone-receptor binding affinity of 4-en-3-one steroids.
Bohl M; Kaufmann G; Hübner M; Reck G; Kretschmer RG
J Steroid Biochem; 1985 Dec; 23(6A):895-900. PubMed ID: 4094417
[TBL] [Abstract][Full Text] [Related]
8. System among the corticosteroids: specificity and molecular dynamics.
Brookes JC; Galigniana MD; Harker AH; Stoneham AM; Vinson GP
J R Soc Interface; 2012 Jan; 9(66):43-53. PubMed ID: 21613285
[TBL] [Abstract][Full Text] [Related]
9. Molecular conformation and protein binding affinity of progestins.
Duax WL; Cody V; Griffin JF; Rohrer DC; Weeks CM
J Toxicol Environ Health; 1978; 4(2-3):205-27. PubMed ID: 351198
[TBL] [Abstract][Full Text] [Related]
10. Relationships of the molecular structure of aldosterone derivatives with their binding affinity for mineralocorticoid receptor.
Yamakawa M; Ezumi K; Shiro M; Nakai H; Kamata S; Matsui T; Haga N
Mol Pharmacol; 1986 Dec; 30(6):585-9. PubMed ID: 3023811
[TBL] [Abstract][Full Text] [Related]
11. How estrogen-specific proteins discriminate estrogens from androgens: a common steroid binding site architecture.
Nahoum V; Gangloff A; Shi R; Lin SX
FASEB J; 2003 Jul; 17(10):1334-6. PubMed ID: 12759331
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship of new steroidal aldosterone antagonists. Comparison of the affinity for mineralocorticoid receptors in vitro and the antialdosterone activity in vivo.
Wambach G; Casals-Stenzel J
Biochem Pharmacol; 1983 May; 32(9):1479-85. PubMed ID: 6222738
[TBL] [Abstract][Full Text] [Related]
13. Molecular conformation, receptor binding, and hormone action of natural and synthetic estrogens and antiestrogens.
Duax WL; Griffin JF; Weeks CM; Korach KS
Environ Health Perspect; 1985 Sep; 61():111-21. PubMed ID: 3905370
[TBL] [Abstract][Full Text] [Related]
14. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity.
Muhn P; Fuhrmann U; Fritzemeier KH; Krattenmacher R; Schillinger E
Ann N Y Acad Sci; 1995 Jun; 761():311-35. PubMed ID: 7625729
[TBL] [Abstract][Full Text] [Related]
15. Molecular structures, conformational analysis, and preferential modes of binding of 3-aroyl-2-arylbenzo[b]thiophene estrogen receptor ligands: LY117018 and aryl azide photoaffinity labeling analogs.
Kym PR; Anstead GM; Pinney KG; Wilson SR; Katzenellenbogen JA
J Med Chem; 1993 Nov; 36(24):3910-22. PubMed ID: 8254621
[TBL] [Abstract][Full Text] [Related]
16. Synthetic 19-nortestosterone derivatives as estrogen receptor alpha subtype-selective ligands induce similar receptor conformational changes and steroid receptor coactivator recruitment than natural estrogens.
García-Becerra R; Borja-Cacho E; Cooney AJ; Smith CL; Lemus AE; Pérez-Palacios G; Larrea F
J Steroid Biochem Mol Biol; 2006 May; 99(2-3):108-14. PubMed ID: 16616843
[TBL] [Abstract][Full Text] [Related]
17. Torsionally and hydrophobically modified 2,3-diarylindenes as estrogen receptor ligands.
Anstead GM; Peterson CS; Pinney KG; Wilson SR; Katzenellenbogen JA
J Med Chem; 1990 Oct; 33(10):2726-34. PubMed ID: 2213825
[TBL] [Abstract][Full Text] [Related]
18. The androgen receptor binding site: a conformational study of steroids in relation with their affinity--I. Interaction with the D-ring.
Schmit JP; Quivy JI; Rousseau GG
J Steroid Biochem; 1980 Dec; 13(12):1387-94. PubMed ID: 7464117
[No Abstract] [Full Text] [Related]
19. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study.
Wiese TE; Polin LA; Palomino E; Brooks SC
J Med Chem; 1997 Oct; 40(22):3659-69. PubMed ID: 9357533
[TBL] [Abstract][Full Text] [Related]
20. Towards the mapping of the progesterone and androgen receptors.
Ojasoo T; Delettré J; Mornon JP; Turpin-VanDycke C; Raynaud JP
J Steroid Biochem; 1987; 27(1-3):255-69. PubMed ID: 3695484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
